Thomas Heineman

Chief Tech/Sci/R&D Officer at ONCOLYTICS BIOTECH INC.

Net worth: 552 334 $ as of 30/05/2024

Health Technology

Consumer Services

Thomas Heineman active positions

Companies	Position	Start	End
ONCOLYTICS BIOTECH INC.	Chief Tech/Sci/R&D Officer	31/07/2020	-

Companies	Position	Start	End
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Corporate Officer/Principal	31/12/2019	30/06/2020
GENOCEA BIOSCIENCES, INC.	Corporate Officer/Principal	31/07/2016	31/12/2019
HALOZYME THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	31/01/2018	31/12/2019
HALOZYME THERAPEUTICS, INC.	Corporate Officer/Principal	31/01/2018	31/12/2019
GSK PLC	Chief Tech/Sci/R&D Officer	31/12/2005	31/07/2016
Saint Louis University School of Medicine	Corporate Officer/Principal	-	-

The University of Chicago

Doctorate Degree

International

Operational

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	3
Doctorate Degree	1

Sectoral

Health Technology	6
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	1
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Health Technology